New Vernon Capital Holdings II’s Harmony Biosciences HRMY Stock Holding History

New Vernon Capital Holdings II’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$127K	Hold	4,541	–	–	0.09%	57
2025 Q4	$170K	Hold	4,541	–	–	0.08%	65
2025 Q3	$125K	Sell	4,541 -10,175	-69%	-$351K	0.06%	64
2025 Q2	$465K	Sell	14,716 -473,708	-97%	-$15.2M	0.22%	28
2025 Q1	$14.7M	Buy	488,424 +473,708	+3,219%	+$17M	0.34%	27
2024 Q4	$506K	Hold	14,716	–	–	0.35%	24
2024 Q3	$589K	Hold	14,716	–	–	0.32%	28
2024 Q2	$444K	Hold	14,716	–	–	0.24%	29
2024 Q1	$494K	Buy	14,716 +680	+5%	+$21.8K	0.26%	36
2023 Q4	$453K	Buy	+14,036	New	+$392K	0.24%	48

Other funds holding HRMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

New Vernon Capital Holdings II's HRMY Position: Q1 2026 in Review

New Vernon Capital Holdings II held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 4,541 shares worth $127K. The position accounts for 0.09% of the portfolio, ranked #57.

New Vernon Capital Holdings II first reported a position in HRMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $14.7M in Q1 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

New Vernon Capital Holdings II held 4,541 shares of Harmony Biosciences worth $127K as of Q1 2026.
New Vernon Capital Holdings II left its Harmony Biosciences share count unchanged in Q1 2026.
Harmony Biosciences made up 0.09% of New Vernon Capital Holdings II's portfolio in Q1 2026, its #57 holding.
New Vernon Capital Holdings II first reported a position in Harmony Biosciences in Q4 2023 and has held it in 10 quarters since.
New Vernon Capital Holdings II's Harmony Biosciences position peaked at $14.7M in Q1 2025.
309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2026, filed 15 May 2026.